Severe pulmonary hypertension without pulmonary fibrosis occurred in 10 patients with the CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, telangiectasia), reputedly a benign variant of progressive systemic sclerosis. Time from the initial symptom, Raynaud's phenomenon, to the recognition of pulmonary hypertension was as long as 40 years. Pulmonary hypertension and increased pulmonary vascular resistance was shown in all patients. Autopsy examination in three of six deaths attributable to pulmonary hypertension showed intimal proliferation with myxomatous change in the small-and medium-sized pulmonary arteries similar to changes in the digital arteries of patients with scleroderma and Raynau...
Systemic scleroderma (SSc) is a multisystem disease with microvascular abnormalities, autoimmune dis...
Pulmonary arterial hypertension is a well-known complication of connective tissue diseases such as s...
A recent consensus categorized pulmonary arterial hypertension (PAH) into multiple groups, including...
Pulmonary hypertension (PH) associated with scleroderma systematica (SDS) is a menacing manifestatio...
Systemic sclerosis is an auto-immune disease characterized by skin involvement that often affects mu...
A retrospective chart review was carried out on 344 patients with systemic sclerosis (SSc) followed ...
BACKGROUND: Pulmonary involvement in systemic sclerosis (SS) is a frequent complication and is assoc...
The CREST syndrome initially described as a limited, more indolent form of diffuse scleroderma, is c...
Contains fulltext : 81797.pdf (publisher's version ) (Closed access)Systemic scler...
Pulmonary hypertension (PH) commonly affects patients with systemic sclerosis (SSc) and is associate...
Background: Pulmonary hypertension (PH), defined by mean pulmonary arterial pressure (PAPm) ≥25 mm H...
Systemic sclerosis (SSc) is a heterogeneous disorder characterised by dysfunction of the endothelium...
Fibrosing alveolitis and arterial pulmonary hypertension are the main cardiopulmonary findings in pa...
Systemic sclerosis (SSc) is a rare chronic disease of unknown cause characterized by diffuse fibros...
Systemic sclerosis is a chronic disorder characterized by vascular damage, immune dysregulation and ...
Systemic scleroderma (SSc) is a multisystem disease with microvascular abnormalities, autoimmune dis...
Pulmonary arterial hypertension is a well-known complication of connective tissue diseases such as s...
A recent consensus categorized pulmonary arterial hypertension (PAH) into multiple groups, including...
Pulmonary hypertension (PH) associated with scleroderma systematica (SDS) is a menacing manifestatio...
Systemic sclerosis is an auto-immune disease characterized by skin involvement that often affects mu...
A retrospective chart review was carried out on 344 patients with systemic sclerosis (SSc) followed ...
BACKGROUND: Pulmonary involvement in systemic sclerosis (SS) is a frequent complication and is assoc...
The CREST syndrome initially described as a limited, more indolent form of diffuse scleroderma, is c...
Contains fulltext : 81797.pdf (publisher's version ) (Closed access)Systemic scler...
Pulmonary hypertension (PH) commonly affects patients with systemic sclerosis (SSc) and is associate...
Background: Pulmonary hypertension (PH), defined by mean pulmonary arterial pressure (PAPm) ≥25 mm H...
Systemic sclerosis (SSc) is a heterogeneous disorder characterised by dysfunction of the endothelium...
Fibrosing alveolitis and arterial pulmonary hypertension are the main cardiopulmonary findings in pa...
Systemic sclerosis (SSc) is a rare chronic disease of unknown cause characterized by diffuse fibros...
Systemic sclerosis is a chronic disorder characterized by vascular damage, immune dysregulation and ...
Systemic scleroderma (SSc) is a multisystem disease with microvascular abnormalities, autoimmune dis...
Pulmonary arterial hypertension is a well-known complication of connective tissue diseases such as s...
A recent consensus categorized pulmonary arterial hypertension (PAH) into multiple groups, including...